Photocatalytic degradation of antibiotic sulfamethizole by visible light activated perovskite LaZnO3
- PMID: 38802232
- DOI: 10.1016/j.jes.2023.08.004
Photocatalytic degradation of antibiotic sulfamethizole by visible light activated perovskite LaZnO3
Abstract
In this work, the perovskite LaZnO3 was synthesized via sol-gel method and applied for photocatalytic treatment of sulfamethizole (SMZ) antibiotics under visible light activation. SMZ was almost completely degraded (99.2% ± 0.3%) within 4 hr by photocatalyst LaZnO3 at the optimal dosage of 1.1 g/L, with a mineralization proportion of 58.7% ± 0.4%. The efficient performance of LaZnO3 can be attributed to its wide-range light absorption and the appropriate energy band edge levels, which facilitate the formation of active agents such as ·O2-, h+, and ·OH. The integration of RP-HPLC/Q-TOF-MS and DFT-based computational techniques revealed three degradation pathways of SMZ, which were initiated by the deamination reaction at the aniline ring, the breakdown of the sulfonamide moieties, and a process known as Smile-type rearrangement and SO2 intrusion. Corresponding toxicity of SMZ and the intermediates were analyzed by quantitative structure activity relationship (QSAR), indicating the effectiveness of LaZnO3-based photocatalysis in preventing secondary pollution of the intermediates to the ecosystem during the degradation process. The visible-light-activated photocatalyst LaZnO3 exhibited efficient performance in the occurrence of inorganic anions and maintained high durability across multiple recycling tests, making it a promising candidate for practical antibiotic treatment.
Keywords: Antibiotics; Density functional theory; Perovskite; Photocatalysis; Toxicity.
Copyright © 2023. Published by Elsevier B.V.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Efficient photodegradation of antibiotics by g-C3N4 and 3D flower-like Bi2WO6 perovskite structure: Insights into the preparation, evaluation, and potential mechanism.Chemosphere. 2024 Jul;359:142286. doi: 10.1016/j.chemosphere.2024.142286. Epub 2024 May 8. Chemosphere. 2024. PMID: 38729439
-
Aqueous photocatalytic oxidation of sulfamethizole.Environ Technol. 2010 Dec 14;31(14):1547-55. doi: 10.1080/09593331003789537. Environ Technol. 2010. PMID: 21275251
-
Construction of BiOCl/bismuth-based halide perovskite heterojunctions derived from the metal-organic framework CAU-17 for effective photocatalytic degradation.Chemosphere. 2024 Jun;357:142114. doi: 10.1016/j.chemosphere.2024.142114. Epub 2024 Apr 23. Chemosphere. 2024. PMID: 38663679
-
Perovskite-related oxynitrides in photocatalysis.Chimia (Aarau). 2013;67(3):162-7. doi: 10.2533/chimia.2013.162. Chimia (Aarau). 2013. PMID: 23574956 Review.
-
A review on visible light active perovskite-based photocatalysts.Molecules. 2014 Dec 1;19(12):19995-20022. doi: 10.3390/molecules191219995. Molecules. 2014. PMID: 25532834 Free PMC article. Review.
Cited by
-
First synthesis of the LaZnO3 biochar perovskite used as a photocatalyst with the enhanced deactivation mechenism and regenerable performance.Sci Rep. 2025 Jul 2;15(1):23149. doi: 10.1038/s41598-025-07226-9. Sci Rep. 2025. PMID: 40603989 Free PMC article.
-
Visible light-driven photocatalytic degradation of rhodamine B and 5-fluorouracil using ZIF-8/GO: unveiling mechanisms.RSC Adv. 2025 Aug 26;15(37):30217-30230. doi: 10.1039/d5ra05177k. eCollection 2025 Aug 22. RSC Adv. 2025. PMID: 40874154 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical